Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107.5 USD | +0.62% | +0.03% | -2.51% |
12:29am | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
12:21am | Edwards Lifesciences first-quarter profit beats estimates on heart devices strength | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.51% | 185B | |
-3.44% | 105B | |
-4.91% | 66.59B | |
+2.61% | 54.66B | |
+17.23% | 47.78B | |
+4.06% | 41.26B | |
+2.55% | 26.95B | |
+2.56% | 26.37B | |
+12.96% | 24.8B | |
-1.73% | 24.6B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Abbott Laboratories : UBS Adjusts Abbott Laboratories' Price Target to $127 From $140 on COVID-19 Testing Sales Estimates; Buy Rating Kept